Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

US STOCKS-Wall St ends near flat after recent gains; healthcare climbs

Mon, 13th May 2013 20:42

* Core U.S. retail sales rise 0.5 percent in April

* Yum Brands falls as monthly Chinese sales drop

* Indexes: Dow down 0.2 pct, S&P flat, Nasdaq up 0.1 pct

By Caroline Valetkevitch

NEW YORK, May 13 (Reuters) - U.S. stocks ended flat onMonday, pausing after hitting record highs last week, butstrength in healthcare issues helped to keep declines in check.

The S&P 500 healthcare sector climbed 0.7 percentand was the day's best performer.

Shares of Theravance jumped 17.9 percent to $41.20after Irish drugmaker Elan agreed to a $1billion deal to buy 21 percent of the royalties that Theravancereceives from GlaxoSmithKline for itsrespiratory drugs.

The day's flat activity follows a third straight week ofgains on the major indexes, with both the Dow and S&P 500setting record closing highs last week. The S&P 500 remains up14.5 percent for the year so far.

While some analysts argue the long-term trend is stillhigher, many see momentum waning in the near term in the absenceof positive catalysts. Volume has been lighter than average, andvolatility has been low in recent days.

"Intraday volatility has essentially been nonexistent. Ithink it means people are really sitting on the sidelines rightnow seeing which way it's going to go," said Uri Landesman,president of Platinum Partners in New York.

The CBOE Volatility index ended down 0.3 percent.

The Dow Jones industrial average was down 26.81points, or 0.18 percent, at 15,091.68. The Standard & Poor's 500Index was up 0.07 points at 1,633.77. The NasdaqComposite Index was up 2.21 points, or 0.06 percent, at3,438.79.

Among the day's decliners, Yum Brands Inc fell 2percent to $68.92. After the market closed on Friday, the fastfood chain operator posted a steep decline in Chinese Aprilsales.

Helping to limit the market's downside, retail sales rose0.1 percent in April, better than the 0.3 percent drop that hadbeen expected, and returning to growth following a decline inMarch. Excluding autos, gasoline and buildingmaterials, core sales rose 0.5 percent. Retail sales account forabout 30 percent of U.S. consumer spending.

Investors are at odds over whether positive economic datacan help the market rise further, or whether it will spell theend of the Federal Reserve's monetary stimulus, which couldderail the rally, said Joseph Tanious, global market strategistat J.P. Morgan Funds.

Other data showed business inventories were unchanged inMarch for a second straight month, versus expectations of 0.3percent rise, suggesting restocking could help second-quartereconomic growth.

Earnings have been mostly better than expected. With 90percent of the S&P 500 having reported, 67.2 percent ofcompanies have topped earnings expectations, according toThomson Reuters data, even with the average over the past fourquarters. Only 46.9 percent have beaten revenue expectations,below the 52 percent average over the past four quarters.

U.S.-listed shares of Perion Network surged 10.6percent to $13.94 after the Israeli consumer Internet companyposted first-quarter earnings.

More News
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.